Tarceva
Erlotinib

Tarceva (erlotinib) is a targeted cancer medicine used to treat advanced or metastatic non-small cell lung cancer (NSCLC) with specific EGFR gene mutations, either as a first-line treatment or after chemotherapy. It is also used in combination with gemcitabine for metastatic pancreatic cancer. Tarceva works by blocking epidermal growth factor receptors (EGFR).

Active ingredient

Tarceva 100mg

1 pack
PackagePer PillSpecial PriceBuy
30 tabs
Free Express Delivery
$20.33
Only $610.00


Tarceva is a cancer medicine that interferes with the growth of cancer cells and slows their spread in the body. Tarceva is used to treat non-small cell lung cancer or pancreatic cancer that has spread to other parts of the body (metastatic). Tarceva is usually given after other cancer medicines have been tried without success.